We cordially invite you to learn how Ostaguard™ can give your surgical implants the best chance of success with our leading edge antibacterial coating technology. Meet our team to discuss the future of implant surgery at the American Academy of Orthopedic Surgeons, AAOS Conference in San Francisco, CA. Visit booth #5622 from February 13-16.
We cordially invite you to learn how Ostaguard™ can give your #implant #surgeries the best chance of success with our leading-edge antimicrobial technology. Meet our team to discuss the future of implant surgery at the North American Spine Society, NASS Conference in Los Angeles, CA. Visit booth #2431 from October 18-20.
"Orthobond, a leader in covalently-bound antimicrobial surface treatments with broad applications in the medical device industry announced today the appointment of Frank P. Cammisa, MD, as the company’s Chief Medical Officer. In this role Dr. Cammisa will provide leadership in clinical research and commercial applications for the technology."
"It’s hard to get through the first hour of the day without worrying about pathogens these days. Princeton, New Jersey-based Orthobond Corporation, is making a dent in this issue, having just released its patented antimicrobial nano surface technology at the American Academy of Orthopaedic Surgeons annual meeting in San Diego."